The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer

[Objectives] To investigate the effects of Euonymus Fortunei extract combined with oxaliplatin on tumor growth and the expression of inflammatory cytokines in colon cancer. [Methods] BALB/c nude mice were subcutaneously injected with CT26 colon cancer cells to establish a xenograft model of colon ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Jiaxuan, Ju Yongle, Liao Jiabao, Ouyang Manzhao, Luo Zhentao, Liao Tianyou, Huang Huacong
Format: Article
Language:zho
Published: Editorial Office of Journal of Colorectal & Anal Surgery 2024-10-01
Series:结直肠肛门外科
Subjects:
Online Access:https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=361&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC5%E6%9C%9F
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136797661626368
author Liu Jiaxuan
Ju Yongle
Liao Jiabao
Ouyang Manzhao
Luo Zhentao
Liao Tianyou
Huang Huacong
author_facet Liu Jiaxuan
Ju Yongle
Liao Jiabao
Ouyang Manzhao
Luo Zhentao
Liao Tianyou
Huang Huacong
author_sort Liu Jiaxuan
collection DOAJ
description [Objectives] To investigate the effects of Euonymus Fortunei extract combined with oxaliplatin on tumor growth and the expression of inflammatory cytokines in colon cancer. [Methods] BALB/c nude mice were subcutaneously injected with CT26 colon cancer cells to establish a xenograft model of colon cancer. Thirty-two nude mice were randomly divided into four groups: the tumor-bearing group, the oxaliplatin intervention group, the Euonymus Fortunei intervention group, and the combined intervention group (Euonymus Fortunei combined with oxaliplatin), with 8 mice in each group. The interventions were continuously administered for 3 weeks. Tumor volume, tumor mass were measured, and the tumor inhibition rate was calculated. The levels of IL-1, IL-6, and TNF-α in serum were measured using ELISA. The expression of IKKβ and NF-κB proteins in tumor tissues was detected by Western blotting. [Results] Compared with the tumor-bearing group, the Euonymus Fortunei intervention group showed no significant difference in tumor volume and tumor mass (P>0.05), but the levels of IL-1, IL-6, and TNF-α in serum and the relative expression of IKKβ and NF-κB proteins in tumor tissues were significantly reduced (P<0.05). Compared with the oxaliplatin intervention group, the combined intervention group showed significantly reduced tumor volume and tumor mass (P<0.05), and a significantly increased tumor inhibition rate (69.26%). The levels of IL-1, IL-6, and TNF-α in serum and the relative expression of IKKβ and NF-κB proteins in tumor tissues were significantly reduced (P<0.05). [Conclusion] Although monotherapy with Euonymus Fortunei did not significantly inhibit tumor growth in colon cancer, its combination with oxaliplatin showed a significant inhibitory effect on tumor growth. This effect may be related to the regulation of the IKKβ/NF-κB signaling pathway by Euonymus Fortunei extract.
format Article
id doaj-art-5b336d4d6370484fbb18c68b6dec47e4
institution OA Journals
issn 1674-0491
language zho
publishDate 2024-10-01
publisher Editorial Office of Journal of Colorectal & Anal Surgery
record_format Article
series 结直肠肛门外科
spelling doaj-art-5b336d4d6370484fbb18c68b6dec47e42025-08-20T02:31:02ZzhoEditorial Office of Journal of Colorectal & Anal Surgery结直肠肛门外科1674-04912024-10-0130560761110.19668/j.cnki.issn1674-0491.2024.05.016The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancerLiu Jiaxuan0Ju Yongle1Liao Jiabao2Ouyang Manzhao3Luo Zhentao4Liao Tianyou5Huang Huacong6Department of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, ChinaDepartment of Gastrointestinal Surgery, Shunde Hospital of Southern Medical University (The First People’s Hospital of Shunde), Foshan 528300, Guangdong, China[Objectives] To investigate the effects of Euonymus Fortunei extract combined with oxaliplatin on tumor growth and the expression of inflammatory cytokines in colon cancer. [Methods] BALB/c nude mice were subcutaneously injected with CT26 colon cancer cells to establish a xenograft model of colon cancer. Thirty-two nude mice were randomly divided into four groups: the tumor-bearing group, the oxaliplatin intervention group, the Euonymus Fortunei intervention group, and the combined intervention group (Euonymus Fortunei combined with oxaliplatin), with 8 mice in each group. The interventions were continuously administered for 3 weeks. Tumor volume, tumor mass were measured, and the tumor inhibition rate was calculated. The levels of IL-1, IL-6, and TNF-α in serum were measured using ELISA. The expression of IKKβ and NF-κB proteins in tumor tissues was detected by Western blotting. [Results] Compared with the tumor-bearing group, the Euonymus Fortunei intervention group showed no significant difference in tumor volume and tumor mass (P>0.05), but the levels of IL-1, IL-6, and TNF-α in serum and the relative expression of IKKβ and NF-κB proteins in tumor tissues were significantly reduced (P<0.05). Compared with the oxaliplatin intervention group, the combined intervention group showed significantly reduced tumor volume and tumor mass (P<0.05), and a significantly increased tumor inhibition rate (69.26%). The levels of IL-1, IL-6, and TNF-α in serum and the relative expression of IKKβ and NF-κB proteins in tumor tissues were significantly reduced (P<0.05). [Conclusion] Although monotherapy with Euonymus Fortunei did not significantly inhibit tumor growth in colon cancer, its combination with oxaliplatin showed a significant inhibitory effect on tumor growth. This effect may be related to the regulation of the IKKβ/NF-κB signaling pathway by Euonymus Fortunei extract.https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=361&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC5%E6%9C%9Fcolon cancereuonymus fortuneioxaliplatinikkβ/nf-κb signaling pathway
spellingShingle Liu Jiaxuan
Ju Yongle
Liao Jiabao
Ouyang Manzhao
Luo Zhentao
Liao Tianyou
Huang Huacong
The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
结直肠肛门外科
colon cancer
euonymus fortunei
oxaliplatin
ikkβ/nf-κb signaling pathway
title The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
title_full The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
title_fullStr The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
title_full_unstemmed The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
title_short The effect of Euonymus Fortunei extract combined with oxaliplatin on the IKKβ/NF-κB signaling pathway in colon cancer
title_sort effect of euonymus fortunei extract combined with oxaliplatin on the ikkβ nf κb signaling pathway in colon cancer
topic colon cancer
euonymus fortunei
oxaliplatin
ikkβ/nf-κb signaling pathway
url https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=361&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC5%E6%9C%9F
work_keys_str_mv AT liujiaxuan theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT juyongle theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT liaojiabao theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT ouyangmanzhao theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT luozhentao theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT liaotianyou theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT huanghuacong theeffectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT liujiaxuan effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT juyongle effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT liaojiabao effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT ouyangmanzhao effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT luozhentao effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT liaotianyou effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer
AT huanghuacong effectofeuonymusfortuneiextractcombinedwithoxaliplatinontheikkbnfkbsignalingpathwayincoloncancer